Target intelligence / Profile preview

Chimeric Antigen Receptor (Universal) (CAR (Universal))

Target
CAR (Universal)
Molecular classification
Synthetic receptor, Engineered receptor, Chimeric receptor
01

Overview

A chimeric antigen receptor (CAR) is a synthetic, engineered receptor that can be introduced into immune cells—most commonly T cells—to enable them to recognize and attack specific targets, such as cancer cells. The term "universal" in this context refers to the ability of CARs to function independently of the major histocompatibility complex (MHC), allowing for broader application across different patients and target antigens.

Other names
Universal CARCAR-T cell therapyEngineered T cell receptor
02

Mechanism of action

CARs bind directly to surface molecules on target cells in an MHC-independent manner, leading to T cell activation, proliferation, cytokine secretion, and target cell lysis.

03

Biological functions

Targeted cell killingT cell activationImmune responseCytokine secretionCell proliferation
04

Disease associations

CancerHematologic malignanciesInfectious diseasesAutoimmunity
05

Safety considerations

Cytokine release syndrome (CRS)Immune effector cell-associated neurotoxicity syndrome (ICANS)On-target, off-tumor toxicityB cell aplasia (for CD19-targeted CARs)Insertional mutagenesisLong-term effects of CAR-T cell persistence
06

Interacting drugs

CAR-T cell products (e.g., tisagenlecleucel, axicabtagene ciloleucel)

2 more in the full profile.

07

Biomarkers

CAR expression level on T cellsTarget antigen expression level on tumor cellsCytokine levels (e.g., IL-6, IFN-gamma)Minimal residual disease (MRD)Persistence of CAR-T cells in vivo

Beyond the preview

Go deeper on Chimeric Antigen Receptor (Universal) (CAR (Universal)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chimeric Antigen Receptor (Universal) (CAR (Universal)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call